The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
opko health | 225 |
schering corporation | 32 |
tesaro | 4 |
shering korporejshn | 2 |
schering corporation | 15 |
opko health | 10 |
tesaro | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
nk1 antagonists | 35 | 2001 |
nk1 antagonists | 31 | 2004 |
intravenous formulations of neurokinin-1 antagonists | 30 | 2009 |
pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-me… 🛈 | 29 | 2006 |
hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-… 🛈 | 28 | 2006 |
process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-e… 🛈 | 25 | 2008 |
hypersulfated disaccharide formulations | 22 | 2009 |
process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-e… 🛈 | 20 | 2007 |
identification of small molecules recognized by antibodies in subjects with neurodegener… 🛈 | 19 | 2009 |
peptoid ligands for isolation and treatment of autoimmune t-cells | 19 | 2009 |